From Research..

Building AI Assistants or Agents begins with the thorough research of the specified task. Often this addresses issues such as identifying internal knowledge assets, ensuring data quality and normalisation.

.. to process pipeline..

Using Large Language Models (LLMs) and retrieval augmented generation (RAG) techniques, we build the application pipeline, that manages the flow of information through the process.

Managing the development process

From detailed application identification to requirement development and delivery, we can help your business identify the steps to create a bespoke genAI solution

What can AIMI do?

AIMI has been developed as an assistant to address medicine information enquiries . The critical issue is to ensure that responses are reliable and their source easily identified. Whether in a busy medicines information pharmacy or a medical information function in a pharmaceutical we wanted to explore how generative AI can provide efficient answers to, often complex, problems.

Gradient AI

Transforming Teams with Cutting-Edge Generative AI Insight and Application Training

Contact us for more details

Gradient AI Upskilling
Programme

  • Programme is based on four sessions but can be configured individually for each client.
  • Foundations of GenAI – ​terminology, key platforms (chatGPT, Google Gemini etc.) how genAI works, prompt engineering, applications and AI agents. This provides familiarity with the current AI landscape.
  • Exploration of potential use cases compatible with departmental objectives –identify those operational tasks that are priorities for the team and where GenAI poses a credible opportunity.  
  • Explore how GenAI applications, such as assistants, should be specified and address issues such as ethics and security.  
  • Review & future potential – ​evaluate how developments can be incorporated by organisations in this fast-moving environment and ensure that the skills of employees are maintained.
request details

ADRx

Adverse drug reaction analysis from reports from the FDA Adverse Event Reporting System (FAERS)

ADRx - analyse drug side effects from FAERS

ADRx from PharmAdvisor is a unique online resource that aids healthcare professionals in accurately screening for and diagnosing adverse drug reactions.

This is accomplished this by evaluating a patient's symptoms and signs with the world's largest, publically available, voluntary reporting databases: the Food and Drug Administration's Adverse Event Reporting System (FAERS).

Results are displayed in clear tables. By using the PRR statistic, users can easily identify which drugs have a higher rate of reporting for specific side effects.

ADRx
Functions

Analyse ADRs

  • Enables immediate comparison for a specific ADR between a patients' medicines.
  • Input symptom or sign to review.
  • Input list of medicines being taken.
  • Observe proportional reporting ratio (PRR). A value greater than 1 indicates a disproportionate number of reports relative to all other medicines.
  • View PRR values for this symptom in other medicines in same class.
  • Extend ADR analysis to include similar concepts e.g. cytopenias.
  • Compare reactions for medicines with the same indication.

Risk assessment

  • For diabetic patients with asthma, for example, the risk assessment function can help identify which medicines that treat asthma have a minimal impact on blood glucose.
  • Risk assessment can be used to assess the reports for a specific ADR across a class of medicines.
  • Risk assessment can be employed when considering medicines for any condition in patients who are susceptible to specific risks.

Tabulated ADRs for all medicines

  • ADRs listed in manufacturers' datasheets are included and organised in tabular format.
  • This makes locating an ADR a simple and efficient task.
  • ADRs are linked to the associated FAERS values, giving users an objective measure of the number reports.
  • ADRs are also organised by the reaction groups.